Secondary |
Asthma |
23.6% |
Cough |
12.1% |
Drug Use For Unknown Indication |
11.5% |
Pneumonia |
6.1% |
Upper Respiratory Tract Infection |
5.5% |
Bronchitis |
4.8% |
Hyperlipidaemia |
3.6% |
Nausea |
3.6% |
Interstitial Lung Disease |
3.0% |
Abdominal Pain Upper |
2.4% |
Constipation |
2.4% |
Hyperuricaemia |
2.4% |
Influenza |
2.4% |
Insomnia |
2.4% |
Intentional Overdose |
2.4% |
Nasal Congestion |
2.4% |
Osteoporosis |
2.4% |
Pharyngitis |
2.4% |
Product Used For Unknown Indication |
2.4% |
Cerebral Infarction |
1.8% |
|
Nasopharyngitis |
9.1% |
Tooth Hypoplasia |
9.1% |
Tremor |
9.1% |
Aggression |
6.1% |
Coma |
6.1% |
Hallucination, Visual |
6.1% |
Mumps |
6.1% |
Neutropenia |
6.1% |
Rhabdomyolysis |
6.1% |
Status Asthmaticus |
6.1% |
Altered State Of Consciousness |
3.0% |
Delirium |
3.0% |
Faeces Discoloured |
3.0% |
Hepatic Function Abnormal |
3.0% |
Hospitalisation |
3.0% |
Hypokalaemia |
3.0% |
Interstitial Lung Disease |
3.0% |
Liver Disorder |
3.0% |
Palpitations |
3.0% |
Tachycardia |
3.0% |
|
Concomitant |
Product Used For Unknown Indication |
28.9% |
Asthma |
27.3% |
Bronchitis |
9.0% |
Drug Use For Unknown Indication |
5.6% |
Upper Respiratory Tract Inflammation |
4.5% |
Pneumonia |
3.2% |
Chronic Obstructive Pulmonary Disease |
2.7% |
Hypertension |
2.7% |
Prophylaxis |
2.5% |
Otitis Media |
2.1% |
Influenza |
1.6% |
Rheumatoid Arthritis |
1.4% |
Rhinitis |
1.3% |
Tonsillitis |
1.3% |
Nasopharyngitis |
1.2% |
Insomnia |
1.2% |
Gastritis |
0.9% |
Diabetes Mellitus |
0.9% |
Psoriatic Arthropathy |
0.9% |
Cardiac Failure |
0.9% |
|
Asthma |
29.2% |
Pneumonia |
8.8% |
Interstitial Lung Disease |
6.5% |
White Blood Cell Count Decreased |
5.6% |
Rhabdomyolysis |
4.6% |
Vomiting |
4.2% |
Abnormal Behaviour |
3.7% |
Dyspnoea |
3.7% |
Drug Eruption |
3.2% |
Nasopharyngitis |
3.2% |
Pyrexia |
3.2% |
Septic Shock |
3.2% |
Death |
2.8% |
Hypoaesthesia |
2.8% |
Liver Disorder |
2.8% |
Respiratory Arrest |
2.8% |
Wheezing |
2.8% |
Hypoglycaemia |
2.3% |
Loss Of Consciousness |
2.3% |
Pneumonia Bacterial |
2.3% |
|
Interacting |
|
Ventricular Extrasystoles |
100.0% |
|